Style | Citing Format |
---|---|
MLA | Mehrizi TZ, Ardestani MS. "Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021)." Current Pharmaceutical Biotechnology, vol. 24, no. 5, 2023, pp. 611-632. |
APA | Mehrizi TZ, Ardestani MS (2023). Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021). Current Pharmaceutical Biotechnology, 24(5), 611-632. |
Chicago | Mehrizi TZ, Ardestani MS. "Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021)." Current Pharmaceutical Biotechnology 24, no. 5 (2023): 611-632. |
Harvard | Mehrizi TZ, Ardestani MS (2023) 'Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021)', Current Pharmaceutical Biotechnology, 24(5), pp. 611-632. |
Vancouver | Mehrizi TZ, Ardestani MS. Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021). Current Pharmaceutical Biotechnology. 2023;24(5):611-632. |
BibTex | @article{ author = {Mehrizi TZ and Ardestani MS}, title = {Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021)}, journal = {Current Pharmaceutical Biotechnology}, volume = {24}, number = {5}, pages = {611-632}, year = {2023} } |
RIS | TY - JOUR AU - Mehrizi TZ AU - Ardestani MS TI - Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021) JO - Current Pharmaceutical Biotechnology VL - 24 IS - 5 SP - 611 EP - 632 PY - 2023 ER - |